// App-Quantinova.ai

2967 : Adding Ultrasound to the Treat-to-Target Strategy Shows No Benefit in Achievement of Remission: Results from the Biodam Cohort

Researchers

Presenter

  • Alexandre Sepriano

Principal Investigators

  • Robert B.M. Landew

  • Dsire van der Heijde

  • Sarah Ohrndorf

  • Oliver Fitz Gerald

  • Marina Backhaus

  • Maggie Larche

  • Joanne Homik

  • Alain Saraux

  • Hilde B. Hammer

  • Lene Terslev

  • Mikkel stergaard

  • Gerd R. Burmester

  • Bernard Combe

  • Maxime Dougados

  • Carol A Hitchon

  • Gilles Boire

  • Robert G. Lambert

  • Rana Dadashova

  • Joel Paschke

  • Edna Hutchings

  • Walter P. Maksymowych

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands

  • University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • ASRI, Dublin, Ireland, Dublin, Ireland

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • McMaster University, Hamilton, ON, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France

  • Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

  • Copenhagen Center for Arthritis Reasearch, Center for Rheumatology and Spine diseases, Glostrup Hospital, Copenhagen, Denmark

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Rhumatology Department, Lapeyronie Hospital and Montpellier University, Montpellier, France

  • Paris Descartes University, Paris, France

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

  • CARE Arthritis, Edmonton, Canada

  • CARE Arthritis, Edmonton, Canada

Locations

  • Netherlands

  • Germany

  • Ireland

  • Canada

  • France

  • Norway

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A